Abstract Hyperhomocysteinemia is a well-known independent marker factor for atherothrombotic diseases and may result from acquired and genetic influences. Several polymorphisms are suspected to be associated with hyperhomocysteinemia, but data are limited and inconsistent. High-throughput genotyping technologies, such as GenomeLab SNPStream, are now available. Moreover, an appropriate selection of SNPs to be analyzed could represent a strong resource to define the role of genetic risk factors. We developed a multiplex PCR-oligonucleotide extension approach by GenomeLab platform. We selected 72 SNPs based on their putative function and frequency in the candidate genes AHCY, BHMT, BHMT2, CBS, ENOSF1, FOLH1, MTHFD1, MTHFR, MTR, MTRR, NNMT, PON1, PON2, SLC19A1, SHMT1, TCN2, and TYMS. We were able to analyze 57 of the SNPs (79%). For MTHFR C677T and A1298C and MTR A2756G SNPs, we compared data obtained with an electronic microchip technology and found 99.2% concordance. We also performed a haplotype analysis. This approach could represent a useful tool to investigate the genotype-phenotype correlation and the association of these genes with hyperhomocysteinemia and correlated diseases.
Introduction
Hyperhomocysteinemia (hyperHcy) has been implicated as an independent marker factor for cardiovascular diseases (McCully 1969; Eikelboom et al. 1999) and is associated with various other diseases and/or clinical conditions including Alzheimer's disease (Clarke et al. 1998) , neural tube defects , schizophrenia (Applebaum et al. 2004 ), end-stage renal disease (Van Guldener and Stehouwer 2003) , osteoporosis (Villadsen et al. 2005 ) and non-insulin-dependent diabetes (De Luis et al. 2005; Rudy et al. 2005) . Moreover, perturbations in methionine metabolism and methylation reactions may be involved in cancer processes, such as colorectal cancer (Singh et al. 2003; Kim 2005; Sharp and Little 2004) . Homocysteine (Hcy) is a highly reactive, sulfur-containing amino acid formed during methionine metabolism in the cell. It is a key branch-point intermediate in the ubiquitous methionine cycle, the function of which is to generate one-carbon methyl groups for transmethylation reactions that are essential for several biological processes. It is estimated that 5 to 7% of the general population have mild to moderate hyperHcy. Mild hyperHcy may result from both acquired (e.g., vitamin deficiencies) and genetic influences (Fowler 2005; Gellekink et al. 2005) . Although hyperHcy has been associated with several diseases, the mechanism of Hcy-induced deleterious effects is not fully elucidated. Among the various mechanisms proposed to explain the harmful effects of Hcy, one is that it modulates the expression of certain genes that may lead to several pathological conditions (Castro et al. 2005) .
Hcy-induced regulation of the expression of genes through the interference of DNA epigenetic phenotype modification (alteration of DNA methylation) (Castro et al. 2006) or by hitherto unknown mechanisms is predicted to lead to pathological conditions either directly or indirectly. Data from the literature provide evidence of 135 genes that either modulate the levels of Hcy (23 genes) or are modulated (112 genes) by elevated levels of Hcy (Sharma et al. 2006 ).
Several genetic polymorphisms in genes coding for enzymes involved in Hcy metabolism are demonstrated or suspected to be associated with hyperHcy. Some of these polymorphisms have a large number of data in the literature, even if not always consistent [e.g., C677T and A1298C in 5,10-methylenetetrahydrofolate reductase (MTHFR), A2756G in methionine synthase (MTR), G80A in solute carrier family 19 (folate transporter), member 1 (SLC19A1), C776G (TCN2)]. In some cases (e.g., C677T and A1298C MTHFR polymorphisms), the rare allele is associated with reduced enzyme activity in vitro (Frosst et al. 1995; Weisberg et al. 1998 ). At present, for a large number of genes involved in methionine metabolism, comprising those most studied, a deeper evaluation of SNPs might be necessary to determine whether they represent a genetic risk for Hcy metabolism perturbation and correlated diseases.
Besides the putative role in influencing homocysteine and homocysteinethiolactone levels (Perla-Kajan et al. 2007) , polymorphisms in enzymes involved in methionine metabolism may also play a role in altering DNA methylation reactions and thus genetic stability and gene expression (Waterland 2006) . Therefore, the pivotal role of methionine metabolism in determining levels of highly reactive homocysteine and in altering genetic stability and gene expression leads us to assume that a study of several polymorphisms in different genes involved in this pathway might be significant.
In the present study, the SNP selection was to permit construction of informative haplotypes in different selected candidate genes, independent of their known role in influencing Hcy levels, to use them in future susceptibility and association studies.
Thus, we evaluated a high-throughput analytical strategy using the GenomeLab SNPStream technology (Beckman Coulter, Fullerton, CA), based on multiplex primer extension reactions. It can be applied in the evaluation of genotype-phenotype correlation and association studies aimed at investigating the role of several genetic polymorphisms in different genes involved in methionine metabolism.
Materials and Methods

Selection of Polymorphisms
We selected SNPs in candidate genes according to their demonstrated or putative function on the basis of literature data, localization in the promoter or regulatory region or exons (SNP causing amino acid substitution), and/or with heterozygosity values greater than 0.300, extracted from the dbSNP database (NCBI, National Center for Biotechnology Information, Bethesda, http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=snp&cmd=search&term=). The annotation of each SNP and its frequency in Caucasian populations were assessed in dbSNP NCBI and ENSEMBL (http://www.ensembl.org/index.html) databases.
Blood Collection and DNA Extraction
Peripheral blood samples were collected from 376 consecutive, Italian, apparently healthy subjects (24-98 years old, median age: 72; male/female: 207/169). To enroll healthy subjects, we excluded those with a history of cardiovascular disease or venous thromboembolic events, evaluated by a questionnaire structured to identify symptom-free subjects and to exclude those who were suspected of having any form of vascular disease. No subject had abnormal liver or renal function.
Genomic DNA was isolated from peripheral whole blood cells using the Flexigene DNA kit (Qiagen, Germany).
Genotyping of 72 Polymorphisms by GenomeLab SNPStream DNA Microarray Technology
All the SNPs were analyzed with GenomeLab SNPStream DNA microarray technology.
Primer Design
Genomic DNA sequences encompassing the polymorphic sites were subjected to a Blast search (Basic Local Alignment Sequence Tool; http://www.ncbi.nlm.nih.gov/ BLAST/) in order to demonstrate highly homologous and repetitive elements. Therefore, a specific software (http://www.autoprimer.com, Beckman Coulter, Fullerton, CA) was used for the design of the 12 pairs of primers for the multiplex PCR and of the 12 tagged extension primers for each panel. PCR primers were designed to amplify a short sequence (90-175 bp) surrounding the polymorphic site for each SNP of interest, while the single-strand tagged extension primers, complementary to the 3 0 sequence flanking the SNP site, permitted the discrimination of the various alleles (Supplementary Table A; data available from the corresponding author on request).
Automation System
The liquid handling in all the reaction protocols is supported by Biomek FX Workstation (Beckman Coulter, Fullerton, CA).
Multiplex PCR and Clean-up Reactions
Multiplex PCR was performed in an MJ thermocycler (MJ Research, Waltham, MA) according to the recommended PCR condition: one denaturation cycle at 94°C for 1 min, 40 cycles with denaturation at 94°C for 1 min, annealing at 55°C for 30 s, and extension at 72°C for 1 min, followed by a final extension at 72°C for 1 min. The reaction was performed in a final volume of 5 ll with 4 ng genomic DNA, 75 lM dNTP mix, 50 nM primer pool, 5 mM MgCl 2 , and 0.5 U Taq polymerase (GoTaq, Promega, Milan, Italy) in PCR 1 9 buffer. PCR products were purified by Exo-Sap reaction (0.67 U exonuclease I and 0.33 U shrimp alkaline phosphatase in 3 ll mix volume), performed in an MJ thermocycler to degrade unincorporated PCR primers and dNTPs (USB Corp., Cleveland), following the recommended conditions: first step at 37°C for 30 min and final incubation at 96°C for 10 min.
Primer Extension Reaction
Extension protocol was performed using an appropriate mix containing TAMRA and Bodipy-fluorescein labeled dideoxynucleotides (ddNTPs) and a pool of 12 allele-specific tagged extension primers. The tagged extension primers can be directed toward a specific location in each well (containing a 4 9 4 oligonucleotide array) of the 384 SNPware plate, because of the presence of a tag at the 5 0 -terminus of the extension primer, complementary to the arrayed oligonucleotides. The 3 0 -terminus of the tagged extension primers is complementary to the sequence strictly adjacent to the SNP site (Denomme and Van Oene 2005) (Fig. 1) . The extension reaction permits the incorporation of dye-labeled dideoxynucleotides at the 3 0 -terminus of the tagged extension primer. In each 4 9 4 array, three positive controls and one negative control were included to ensure accuracy in the genotype determination (Fig. 1) . The extension reaction was performed in an MJ thermocycler according to the recommended extension conditions: a cycle at 96°C for 3 min, 44 cycles with a first step at 94°C for 20 sec and a second step at 40°C for 11 sec, Biochem Genet (2008) 46:406-423 409 and final hold at 4°C. The reaction was performed in a final volume of 15 ll with 0.04 ll SNP extension mix, 5.6 ll SNPware Extension Dilution Buffer, 0.3 ll SNP 20 9 extension mix, and 0.03 ll SNPware DNA polymerase (Beckman Coulter, Fullerton, CA). The SNP 20 9 extension mix contains the dye-labeled dideoxynucleotides, used in the primer extension reaction, and self-annealing oligonucleotides that are extended with dye-labeled terminators; these probes serve as positive controls in each well.
Hybridization Reaction
The primer extension products were transferred to the 384 SNPware plate, previously washed three times with 1 9 SNPware Wash Buffer I, so that each extended primer would hybridize in a specific way to one of the unique probes arrayed in each well. A 12 ll volume of hybridization mix (Beckman Coulter, Fullerton, CA) was added to each well of the plate containing the primer extension products; thus, 8 ll of the previous mixture was transferred to the corresponding well of the SNPware plate. The SNPware plate with the hybridization mix was incubated at 42°C for 2 h (±15 min) in a humid chamber. Thereafter, the SNPware plate was washed three times, adding 1 9 SNPware Wash Buffer II to each well to remove the probes not arrayed. 
Data Analysis
The SNPware plate was analyzed with the GenomeLab SNPStream array imager. Blue and green lasers (488 and 532 nm, respectively) detected the fluorescent color of the extended base for each spot. GetGenos software performed the image analysis, assigning the genotype to each SNP spot on the basis of the relative fluorescence intensity for any SNP. Self-annealing oligonucleotides, extended with dye-labeled ddNTPs as described previously (extension reaction) and hybridized to specific probes in each 4 9 4 array, are used to get a correct grid alignment. The top-left location of the 4 9 4 array contained a mixture of two probes hybridizing to selfextending oligonucleotides that can incorporate both blue and green dye-labeled ddNTPs (heterozygous control), while the top-right and the bottom-left positions had probes that hybridized to self-extending oligonucleotides incorporating just blue or green dye-labeled ddNTPs, respectively (homozygous controls) (Fig. 1) . Moreover, the bottom-right location had probes that were not self-extending and lacked complementarity to any DNA in the reaction (negative control).
In the genotype analysis, three possible calls to each spot in the 384 SNPware plate can be obtained and collected into three clusters, one representing the homozygous XX genotype (as shown in the rightmost side of the graph), one representing the heterozygous XY genotype (central cluster), and one representing the homozygous YY genotype (as shown in the leftmost side of the graph) ( Fig. 2) (Huang et al. 2004) . Plot data can be finally converted into an Excel format by the software itself, registering the genotype observed for each SNP in the samples analyzed.
Genotyping Three Polymorphisms by Nanogen Technology
The MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), and MTR A2756G (rs1805087) gene polymorphisms were evaluated by the NanoChip Molecular Biology Workstation (NanoChip cartridge, Nanogen, San Diego, CA), using the protocol extensively described in a previous paper (Giusti et al. 2004) . MTHFR and MTR gene sequences were obtained from GeneBank (http://www.ncbi.nlm.nih.gov, accession nos. AL953897.6 and AC013268.5). The oligonucleotides used for PCR and for hybridization, along with the melting, annealing, and stringency temperatures, are reported in Supplementary Table B (data available from the corresponding author on request). The software of the system directly assigned the genotype to each sample.
Linkage Disequilibrium and Haplotype Analysis
To prepare data files for linkage disequilibrium by SNPalyze software and for haplotype reconstruction analysis by Phase version 2.1 software, data files obtained by GetGenos SNPStream software were processed in the R environment (http:// www.r-project.org).
Pairwise linkage disequilibrium was evaluated using SNPalyze software (Dynacom, Chiba, Japan).
The Phase version 2.1 software (Scheet and Stephens 2006) is an implementation of the Bayesian method of haplotype reconstruction, allowing use of a priori expectations to assign haplotypes correctly to individuals in a dataset. Phase uses a Gibb's sampling algorithm, a type of Markov chain-Monte Carlo algorithm, to obtain an approximate sample from the posterior distribution of Pr(H|G), where H is the unknown haplotype pair and G is the known genotype.
Results
We selected 72 SNPs in 17 candidate genes: 7 in MTHFD1 [methylenetetrahydrofolate dehydrogenase (NADP + dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase], 5 in NNMT (nicotinamide N-methyltransferase), 3 in PON1 (paraoxonase 1), 2 in PON2 (paraoxonase 2), 5 in TCN2 (transcobalamin II), 4 in AHCY (S-adenosylhomocysteine hydrolase), 7 in MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), 5 in BHMT (betaine-homocysteine methyltransferase), 3 in FOLH1 [folate hydrolase (prostate-specific membrane antigen) 1], 5 in MTHFR [5,10-methylenetetrahydrofolate reductase (NADPH)], 6 in MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), 2 in TYMS (thymidylate synthetase), 1 in ENOSF1 (enolase superfamily member 1), 3 in SHMT1 [serine hydroxymethyltransferase 1 (soluble)], 5 in SLC19A1 [solute carrier family 19 (folate transporter), member 1], 7 in CBS (cystathionine-beta-synthase), and 2 in BHMT2 (betaine-homocysteine methyltransferase 2).
They were analyzed in six panels of 12 SNPs each, according to their nucleotide substitution (1 AT, 1 CA, 1 GC, 1 GA, and 2 CT panels).
The conversion rate among the six panels ranged from 67 to 100%, with 12/12 SNPs working in 1 panel, 10/12 in 1 panel, 9/12 in 3 panels, and 8/12 in 1 panel. Therefore, we could analyze 57 out of 72 (79.2%) SNPs. If we excluded the panel with the higher number of failed SNPs, we observed a conversion rate of 81.7% for oligonucleotides designed by Autoprimer software.
We genotyped 376 subjects. The genotype distribution and allele frequency of the 57 SNPs are reported in Table 1 . At the first analysis, the median number of called samples was 340 (range: 136-368), with a median percentage of called samples of 90.4 (range: 36.2-97.9%).
All the passed SNPs under study resulted in Hardy-Weinberg equilibrium. For the polymorphisms C677T and A1298C in the MTHFR gene and A2756G in the MTR gene, we compared data obtained with the high-throughput GenomeLab SNPStream technology with those obtained with the low-to-medium throughput Nanogen electronic microchip technology in 288 subjects. We found a 99.2% concordance between the results obtained with the two technologies. This concordance was observed for all of the samples independent of the genotype and the SNPs studied. For the seven discordant samples, 6/7 discordant genotypes had low fluorescence signals in the Nanogen analysis, and the repetition of the PCR and Nanogen analysis confirmed the genotype identified by the SNPStream technology. The direct sequencing of the 1/7 discordant genotype with apparently the correct genotype with the two platforms demonstrated that the correct genotype was that identified by SNPStream technology (data not shown).
Pairwise Linkage Disequilibrium Measurement and Haplotype Reconstruction
The pairwise linkage disequilibrium between all pairs of SNP markers of a gene in the subjects studied is reported in Supplementary Table C (data available from the corresponding author on request), as indicated by the D 0 , r 2 , Akaike's information criterion, and P value for the chi-squared test (Stephens et al. 2001) . Several genes among those investigated showed a high percentage of SNP, with D 0 values greater than 0.5. These data suggested that sequence variants within the considered gene are in strong disequilibrium. Table 2 shows the results of the haplotype reconstruction analysis that we used in association analyses. All haplotypes with an estimated frequency higher than 0.01 are reported.
Comparative Cost Analysis Table 3 compares the costs of the GenomeLab SNPStream technology with respect to a low-to-medium throughput technology, the electronic microchip technology, and a classical manual approach such as RFLP analysis. The cost per SNP of the electronic microchip technology was 3.85 times that of the SNPStream, and RFLP analysis cost 4.26 to 9.92 times as much.
Discussion
The emerging role of single-nucleotide polymorphism in clinical association and pharmacogenetic studies has created a need for high-throughput genotyping technologies.
In this study, we describe the development, optimization, and validation of a microarray approach using a commercial system, GenomeLab SNPStream technology, based on the minisequencing single-nucleotide primer extension principle, for large-scale SNP detection in genes encoding molecules involved in Hcy metabolism.
Mild hyperHcy is an established independent marker factor for atherothrombotic diseases (Eikelboom et al. 1999; McCully 1996) . The multifactorial pathogenesis of this disorder includes environmental and genetic factors interacting to produce high plasma Hcy levels (Fowler 2005; Gellekink et al. 2005) .
Polymorphic variants in genes encoding enzymes involved in Hcy metabolism (MTHFR, MTR, MTRR, CBS) (Frosst et al. 1995; Weisberg et al. 1998 ) influence their expression and functional activities and have been proposed as susceptibility factors for hyperHcy. Several studies are available in the literature that investigate the genetic factors involved in hyperHcy, but they did not involve sufficient numbers of patients and/or SNPs to assure statistically valid conclusions (Lewis et al. 2005) .
The heterogeneous nature of this complex trait highlights the need to study a larger number of samples and SNPs to perform genetic association studies useful in the evaluation of the underlying genetic causes of hyperHcy and of the mechanisms at the basis of the beginning and of the progression of cardiovascular diseases. Moreover, understanding the genetic architecture of the complex polygenic trait, namely hyperHcy, or in general the misregulation of methionine metabolism is a fundamental goal of the biological and medical research involved in other fields such as cancer and neurological disorders (Gellekink et al. 2005; Sharma et al 2006; Kwok 2001) .
Association studies need to genotype a dense set of SNPs in a large panel of individuals and to test each SNP, or set of local haplotypes constructed from the SNP data, in the genotype-phenotype association. Even with some a priori knowledge of a candidate gene region contributing to a disease phenotype, a large number of SNPs need to be genotyped in an association study to ensure one of the genotyped SNPs is causative or is in strong linkage disequilibrium with the causative site. It is also important that SNPs are genotyped in a very large panel of individuals to provide sufficient power to detect variants that may have only subtle phenotypic effects. During the last decade the wide-ranging application of SNP in research and molecular diagnostics has required further development of robust, flexible, costeffective technology platforms for scoring genotypes in large numbers of samples to evaluate the genotype-phenotype correlation. Moreover, after the pathogenetic role of a polymorphism/mutation is identified, clinical diagnosis (diagnostic test) for analysis of many SNPs in large sample sets will be required, which must satisfy the quality features needed in the routine of a molecular genetic laboratory. A plethora of SNP genotyping platforms is currently available (Kwok 2001; Syvanen 2001 Syvanen , 2005 , offering different advantages and disadvantages with respect to the characteristics of the technology (principle, cost, automation) and to the type of study to be performed. (Giusti et al. 2004) Among the available advanced technologies, first we chose low-throughput Nanogen technology (100-1400 SNPs for chip) (Giusti et al. 2004 ) and more recently high-throughput GenomeLab SNPStream technology, based on the primer extension principle (Denomme and Van Oene 2005) . The latter system uses fluorescent multiplex SNP-IT primer extension assays for allele determination of previously discovered SNPs and allows genotyping of up to 890,000 SNP genotypes per day, with only 4 ng of genomic DNA (Huang et al. 2004 ).
In the current study we selected and analyzed SNPs in 17 genes that may play a role in modulating Hcy plasma levels and/or DNA methylation reactions, so altering genetic stability and gene expression. In each gene we identified several polymorphisms independent from their known role in influencing Hcy levels and DNA methylation reactions. We chose SNPs according to their demonstrated or putative function evaluated on the basis of literature data, their localization in the promoter or other regulatory regions or exons, and their potential utility in haplotype reconstruction.
Among the 72 selected SNPs, 57 passed all the steps in the software-and technician-surveilled quality check and were thus suitable for the genotyping analysis. The conversion rate of 79.2% rose to 81.7% if we excluded the panel with the higher number of failed SNPs among the six designed panels.
Adherence to Hardy-Weinberg equilibrium (HWE) is a common criterion to assess the quality of a genotyping assay, as a deviation can suggest incorrect genotype assignments (Hosking et al. 2004 ). However, selection, mutation, or migration can also cause deviation from HWE, and the power to detect these processes increases with the sample size. Of our 57 converted assays, no SNP showed a deviation from HWE.
In the first analysis, our data showed a call rate higher than 90%, meaning that less than 10% of the samples needed to be reanalyzed. This is an important issue, as the higher the call rate, the lower the need for further analysis, which reduces costs and time of analysis and increases the benefit of automation.
The analysis of linkage disequilibrium of the SNPs and of the haplotype reconstruction indicates that the selected SNPs could be suitable to investigate and could illuminate the role of genes involved in Hcy metabolism in determining plasma Hcy levels and clinical phenotypes.
In this study we compared data from two technologies available in our laboratory, the Nanogen technology and the GenomeLab SNPStream technology. Our data demonstrated 99.2% concordance between the results obtained by the two technologies. We observed that six of the seven discordant samples were failed by the Nanogen technology because of their low signal-to-noise ratio. The repetition of PCR and analysis by Nanogen technology of the six samples confirmed the results obtained by the GenomeLab SNPStream technology. Concerning one sample, the repetition of the analysis by the two technologies confirmed the discordant result. The direct sequencing analysis showed that the correct genotype was that obtained using the GenomeLab SNPStream technology. This datum confirms the expected higher accuracy of primer extension based technologies in allele discrimination.
Genomelab SNPStream is a cost-effective and time-saving alternative. In fact, the cost of this high-throughput technology is a quarter that of the Nanogen technology and can be as little as a tenth the cost of a classical RFLP genotyping assay. Moreover, this technology permits shorter analysis time compared with Nanogen and RFLP approaches (16% and 88%, respectively), resulting in the possibility of increasing the number of genotyped SNPs over which to amortize the cost of the instrument.
In conclusion, our data highlight that the described approach using the commercially available high-throughput GenomeLab SNPStream technology offers considerable advantages for SNP genotyping on a large scale, representing a useful tool to investigate the genotype-phenotype correlation and the association between the methionine cycle genes and hyperHcy and/or diseases correlated to methionine metabolism alterations, as well as other complex multifactorial traits.
